Autism Spectrum Disorder Clinical Trial

The Institute, an exempt non-governmental organization (NGO) founded in 1998, is pleased to announce a strategic alliance with AMARANTH LIFE SCIENCES PHARMACEUTICAL, INC, a medical food formulation company headed by Dr. Walter Wolf. The company specializes in formulations built around ethically harvested ovine placenta, nano gold, and other natural ingredients, carried by oils such as Sachi Inchi.

We are working with the Institute for Health Research’s Institutional Review Board (IRB), under its Chairperson, Robert Goodman PhD and the Clinical Trial Principle Investigator, Ab Boonswang, MD.

The “MEDICAL MANNA™ THRIVE MEDICAL FOOD FOR CLINICAL MANAGEMENT OF AUTISM SPECTRUM DISORDER (ASD)” Clinical Trial formulation is being offered to selected children and adults suffering from autism spectrum disorders as a medical food for the dietary management of their condition, supporting normal structure and function.

Our preliminary clinical experience strongly suggests that the Clinical Trial will be successful.

Under the 2005 Orphan Drugs Act, and over the years, the physicians who have recommended Medical Manna tell us they have seen excellent improvement using this nutritional management for autism spectrum disorder. The independent Institute for Health Research is overseeing a clinical trial of 1000 autism patients. The clinical trial is to document and make broadly available the excellent clinical results experienced in the past.

Ab Boonswang, MD is an active cardio surgeon with six children. He is the Principal Investigator and has been using the Amaranth Life Sciences products for over a year. He has been quite satisfied with the results within his own family. Dr. Boonswang is being assisted by a team that includes other health care professionals under the Institutional Review Board.

The problem of autism spectrum disorder is a worldwide problem. Through this extensive clinical trial he expects to demonstrate the enormous potential to improve the lives of autism spectrum disorder patients.

1 We are seeking patient candidates for trial. Please reply to this email if you are interested.

2 We are also seeking contributions to fund the trial. Your help is urgently needed. Please read on.

The Clinical Trial Protocol, with memorandums from the scientific staff and projected budget, are available for inspection at the Institute website; see

The Institute has initiated a Crowd Funding Program to accept donations to support the Clinical Trial. Your donation receipt will be generated by the donation system. You may use any credit or debit card to through this Chesed Fund appeal. Please give generously.

Foundations or other grant-issuing organizations may contact the undersigned for procedures for grants, gifts and bequests. Donations, of whatever amount, will enable the Institute to provide the Medical Food for children and adults in need.

The Principle Investigator expects to publish the Clinical Trial Report upon completion of the trial in conformity with the IRB approved Clinical Trial Protocol.

Ralph Fucetola JD

President IHR


The Institute:

Short Link to this Cause:

Recent Donations

effective amount

Be the first to donate to this cause